KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Inovio Pharmaceuticals (INO) over the last 16 years, with Q3 2025 value amounting to $8.9 million.

  • Inovio Pharmaceuticals' Change in Acquisitions & Divestments fell 7700.44% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.8 million, marking a year-over-year decrease of 6892.23%. This contributed to the annual value of $158.6 million for FY2024, which is 4432.45% down from last year.
  • Per Inovio Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $8.9 million for Q3 2025, which was down 7700.44% from $10.3 million recorded in Q2 2025.
  • Inovio Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $123.1 million during Q1 2022, with a 5-year trough of $7620.0 in Q1 2025.
  • In the last 5 years, Inovio Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $49.0 million in 2023 and averaged $52.6 million.
  • In the last 5 years, Inovio Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 2429322.69% in 2022 and then tumbled by 9998.62% in 2025.
  • Over the past 5 years, Inovio Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $34.6 million in 2021, then soared by 186.23% to $99.1 million in 2022, then plummeted by 50.56% to $49.0 million in 2023, then fell by 29.45% to $34.6 million in 2024, then crashed by 74.16% to $8.9 million in 2025.
  • Its Change in Acquisitions & Divestments was $8.9 million in Q3 2025, compared to $10.3 million in Q2 2025 and $7620.0 in Q1 2025.